Status:
TERMINATED
Implantation of Markers for the Radiotherapy of Lung Cancer Patients
Lead Sponsor:
Virginia Commonwealth University
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
This clinical trial studies imaging markers in planning radiation therapy in patients with lung cancer. Implanting markers in the tumor that can be seen using imaging procedures during radiation thera...
Detailed Description
OBJECTIVES: * To acquire experience in the marker implantation process for mediastinal lymph nodes and primary lung tumors in patients with stage I-IIIB non-small cell lung cancer. * To characterize ...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Diagnosis of non-small cell lung cancer
- Stage I-IIIB disease
- No prior surgical tumor resection
- Respiration-induced tumor motion \> 5 mm
- Recruited by attending physician or research nurse at the Medical College of Virginia Hospitals
- PATIENT CHARACTERISTICS:
- Not pregnant
- No insufficient lung function or other parameters prohibiting a bronchoscopy
- Not a prisoner or institutionalized
- PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
- Concurrent chemotherapy allowed
Exclusion
Key Trial Info
Start Date :
February 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2012
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT00856427
Start Date
February 1 2008
End Date
August 1 2012
Last Update
December 20 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Virginia Commonwealth University Massey Cancer Center
Richmond, Virginia, United States, 23298-0037